Clinical Practice Statement on Direct Oral Anticoagulant Use in Society of Gynecologic Oncology Released
January 14, 2021
January 14, 2021
CHICAGO, Jan. 14 (TNSJou) -- The Society of Gynecologic Oncology issued the following news release:
Venous thromboembolism (VTE) is a common cause of morbidity and mortality in women with gynecologic malignancies. The January 2021 edition of Gynecologic Oncology has published "Direct oral anticoagulant use in gynecologic oncology: A Society of Gynecologic Oncology Clinical Practice Statement," to provide clinical data and overall quality of evidence regarding the use of di . . .
Venous thromboembolism (VTE) is a common cause of morbidity and mortality in women with gynecologic malignancies. The January 2021 edition of Gynecologic Oncology has published "Direct oral anticoagulant use in gynecologic oncology: A Society of Gynecologic Oncology Clinical Practice Statement," to provide clinical data and overall quality of evidence regarding the use of di . . .